Stay updated on Emapalumab Clinical Trial in MAS/sHLH
Sign up to get notified when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.

Latest updates to the Emapalumab Clinical Trial in MAS/sHLH page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the revision history. This update is an administrative change to the page's revision record and does not modify study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a dedicated Locations section including Ohio, updating where the study is conducted. Removed the HHS Vulnerability Disclosure footer link and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedTwo minor text updates were made: the Publications note now states that items are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoval of the government funding status banner from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedCore study information appears unchanged between the screenshots; only minor formatting or layout adjustments are visible.SummaryDifference0.4%

- Check103 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

Stay in the know with updates to Emapalumab Clinical Trial in MAS/sHLH
Enter your email address, and we'll notify you when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.